"Trans-Activators" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.
Descriptor ID |
D015534
|
MeSH Number(s) |
D12.776.260.755 D12.776.930.900 D12.776.964.925.984
|
Concept/Terms |
Trans-Activators- Trans-Activators
- Trans Activators
- Transactivators
- Trans-Activator
- Trans Activator
- Transactivator
- Trans-Acting Factor
- Factor, Trans-Acting
- Trans Acting Factor
- Trans-Acting Factors
- Factors, Trans-Acting
- Trans Acting Factors
Nuclear Trans-Acting Factor- Nuclear Trans-Acting Factor
- Factor, Nuclear Trans-Acting
- Nuclear Trans Acting Factor
- Trans-Acting Factor, Nuclear
|
Below are MeSH descriptors whose meaning is more general than "Trans-Activators".
Below are MeSH descriptors whose meaning is more specific than "Trans-Activators".
This graph shows the total number of publications written about "Trans-Activators" by people in this website by year, and whether "Trans-Activators" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 11 | 2 | 13 |
1995 | 12 | 4 | 16 |
1996 | 17 | 4 | 21 |
1997 | 19 | 6 | 25 |
1998 | 25 | 9 | 34 |
1999 | 32 | 15 | 47 |
2000 | 36 | 13 | 49 |
2001 | 27 | 11 | 38 |
2002 | 30 | 22 | 52 |
2003 | 60 | 45 | 105 |
2004 | 62 | 46 | 108 |
2005 | 67 | 37 | 104 |
2006 | 39 | 21 | 60 |
2007 | 21 | 28 | 49 |
2008 | 27 | 14 | 41 |
2009 | 19 | 20 | 39 |
2010 | 10 | 18 | 28 |
2011 | 8 | 23 | 31 |
2012 | 14 | 10 | 24 |
2013 | 12 | 9 | 21 |
2014 | 8 | 11 | 19 |
2015 | 14 | 14 | 28 |
2016 | 8 | 8 | 16 |
2017 | 8 | 10 | 18 |
2018 | 8 | 4 | 12 |
2019 | 8 | 10 | 18 |
2020 | 3 | 1 | 4 |
2021 | 1 | 3 | 4 |
2022 | 1 | 2 | 3 |
2023 | 1 | 0 | 1 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Trans-Activators" by people in Profiles.
-
Doxycycline for transgene control disrupts gut microbiome diversity without compromising acute neuroinflammatory response. J Neuroinflammation. 2024 Jan 04; 21(1):11.
-
CFP1 governs uterine epigenetic landscapes to intervene in progesterone responses for uterine physiology and suppression of endometriosis. Nat Commun. 2023 06 03; 14(1):3220.
-
Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia. Nat Commun. 2022 09 14; 13(1):5401.
-
Osteocyte CIITA aggravates osteolytic bone lesions in myeloma. Nat Commun. 2022 06 27; 13(1):3684.
-
The Chd4 subunit of the NuRD complex regulates Pdx1-controlled genes involved in ?-cell function. J Mol Endocrinol. 2022 06 14; 69(2):329-341.
-
Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia. Oncogene. 2021 10; 40(43):6166-6179.
-
Pancreatic Differentiation of Stem Cells Reveals Pathogenesis of a Syndrome of Ketosis-Prone Diabetes. Diabetes. 2021 10; 70(10):2419-2429.
-
Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients. J Exp Med. 2021 07 05; 218(7).
-
UPF1 reduces C9orf72 HRE-induced neurotoxicity in the absence of nonsense-mediated decay dysfunction. Cell Rep. 2021 03 30; 34(13):108925.
-
MKL1 cooperates with p38MAPK to promote vascular senescence, inflammation, and abdominal aortic aneurysm. Redox Biol. 2021 05; 41:101903.